ID29082A - Komposisi liposom imunogenik - Google Patents

Komposisi liposom imunogenik

Info

Publication number
ID29082A
ID29082A IDW20010900A ID20010900A ID29082A ID 29082 A ID29082 A ID 29082A ID W20010900 A IDW20010900 A ID W20010900A ID 20010900 A ID20010900 A ID 20010900A ID 29082 A ID29082 A ID 29082A
Authority
ID
Indonesia
Prior art keywords
imunogenic
liposomic composition
liposomic
composition
imunogenic liposomic
Prior art date
Application number
IDW20010900A
Other languages
English (en)
Indonesian (id)
Inventor
Gary Fujii
Donald V Cramer
William A Ernst
Jill Adler-More
L Jeanne Perry
Original Assignee
Molecular Express Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Express Inc filed Critical Molecular Express Inc
Publication of ID29082A publication Critical patent/ID29082A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IDW20010900A 1998-09-22 1999-09-02 Komposisi liposom imunogenik ID29082A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10135198P 1998-09-22 1998-09-22
US40072399A 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
ID29082A true ID29082A (id) 2001-07-26

Family

ID=26798150

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010900A ID29082A (id) 1998-09-22 1999-09-02 Komposisi liposom imunogenik

Country Status (31)

Country Link
EP (1) EP1115382B1 (hu)
JP (1) JP2002526436A (hu)
KR (1) KR100592825B1 (hu)
CN (1) CN1555254A (hu)
AP (1) AP2010A (hu)
AT (1) ATE468108T1 (hu)
AU (1) AU766772B2 (hu)
BG (1) BG65675B1 (hu)
BR (1) BR9914004A (hu)
CA (1) CA2344173C (hu)
CY (1) CY1110718T1 (hu)
CZ (1) CZ20011013A3 (hu)
DE (1) DE69942393D1 (hu)
DK (1) DK1115382T3 (hu)
EA (1) EA004797B1 (hu)
EE (1) EE200100168A (hu)
ES (1) ES2345695T3 (hu)
GE (1) GEP20053444B (hu)
HK (1) HK1039064A1 (hu)
HU (1) HUP0105391A3 (hu)
ID (1) ID29082A (hu)
IL (2) IL141675A0 (hu)
MX (1) MXPA01002973A (hu)
NO (1) NO330685B1 (hu)
NZ (2) NZ528055A (hu)
OA (1) OA11657A (hu)
PL (1) PL206260B1 (hu)
SK (1) SK287670B6 (hu)
UA (1) UA75327C2 (hu)
WO (1) WO2000016746A2 (hu)
ZA (1) ZA200101829B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006235507B2 (en) * 2005-04-12 2012-08-30 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
TWI583403B (zh) 2009-06-04 2017-05-21 國立感染症研究所 黴漿菌感染症用疫苗
EA034702B1 (ru) 2011-04-26 2020-03-10 Молекулар Экспресс, Инк. Липосомные композиции
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
JP2020515629A (ja) * 2017-04-04 2020-05-28 アヴィディア テクノロジーズ, インコーポレイテッド 免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用
KR20240033309A (ko) * 2022-09-05 2024-03-12 주식회사 차백신연구소 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
SE462375B (sv) * 1985-10-15 1990-06-18 Morgaardshammar Ab Centro Traadblock
EP0247497B1 (en) 1986-05-20 1992-03-04 Wako Pure Chemical Industries, Ltd. Novel functionalized liposomes and a process for production thereof
FR2754543B1 (fr) 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires

Also Published As

Publication number Publication date
AP2010A (en) 2009-06-29
EP1115382B1 (en) 2010-05-19
NZ528055A (en) 2005-01-28
CY1110718T1 (el) 2015-06-10
EA004797B1 (ru) 2004-08-26
PL348604A1 (en) 2002-06-03
AU766772B2 (en) 2003-10-23
CA2344173A1 (en) 2000-03-30
OA11657A (en) 2004-12-08
KR20010075261A (ko) 2001-08-09
HK1039064A1 (en) 2002-04-12
BR9914004A (pt) 2001-07-24
WO2000016746A3 (en) 2000-11-23
AU6035199A (en) 2000-04-10
EA200100269A1 (ru) 2001-12-24
MXPA01002973A (es) 2003-03-27
ZA200101829B (en) 2002-06-05
HUP0105391A2 (hu) 2002-05-29
NO20011406L (no) 2001-04-24
ES2345695T3 (es) 2010-09-29
DE69942393D1 (de) 2010-07-01
CN1555254A (zh) 2004-12-15
WO2000016746A8 (en) 2000-08-10
CZ20011013A3 (cs) 2002-03-13
EP1115382A2 (en) 2001-07-18
BG105372A (en) 2001-10-31
DK1115382T3 (da) 2010-09-06
BG65675B1 (bg) 2009-06-30
CA2344173C (en) 2010-02-23
HUP0105391A3 (en) 2006-02-28
NO20011406D0 (no) 2001-03-20
UA75327C2 (en) 2006-04-17
KR100592825B1 (ko) 2006-06-23
EE200100168A (et) 2002-06-17
NO330685B1 (no) 2011-06-06
IL141675A0 (en) 2002-03-10
WO2000016746A9 (en) 2000-09-21
SK287670B6 (sk) 2011-05-06
SK3222001A3 (en) 2001-09-11
NZ510442A (en) 2003-10-31
AP2001002096A0 (en) 2001-03-31
ATE468108T1 (de) 2010-06-15
WO2000016746A2 (en) 2000-03-30
IL141675A (en) 2007-06-17
PL206260B1 (pl) 2010-07-30
JP2002526436A (ja) 2002-08-20
GEP20053444B (en) 2005-02-25

Similar Documents

Publication Publication Date Title
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
ATE282312T1 (de) Mikrobizide zusammensetzung
ID29430A (id) Komposisi herbisida
IS5430A (is) Ný samsetning
ID26926A (id) Komposisi shampo pembentuk mode
DE69812370D1 (de) Landwirtschaftliche zusammensetzung
ID25508A (id) Komposisi dematologis
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69915204D1 (de) Stabilisierte Proteinzusammensetzung
ID21009A (id) Komposisi untuk supositori
ID23250A (id) Komposisi paroksetin
ID21906A (id) Komposisi adesif
DE69717927T2 (de) Insektizide Zusammensetzung
ID22405A (id) Komposisi pestisida
DE69824331D1 (de) Fungizide Zusammensetzung
ID29082A (id) Komposisi liposom imunogenik
ID26295A (id) Komposisi keras-ultraviolet
DK0862850T3 (da) Mejetærsker
ID26485A (id) Komposisi paroksetina
DE998539T1 (de) Kühlmittelzusammensetzung
ID28359A (id) Komposisi
DE69939964D1 (de) Gelförmige Zusammensetzung
DE69700503D1 (de) Fungizide Zusammensetzung